Samir Softic
Impact in
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment
- Adipokines, Inflammation, and Metabolic Diseases
-
- Diet, Metabolism, and Disease
Papers in
-
- Diet, Metabolism, and Disease 17
- Epidemiology 21
- Liver Disease Diagnosis and Treatment 18
- Adipokines, Inflammation, and Metabolic Diseases 3
- Co-authors
- C. Ronald Kahn (25 shared papers)David E. Cohen (4 shared papers)Shiho Fujisaka (8 shared papers)Rohit Kohli (9 shared papers)Senad Divanovic (5 shared papers)Christopher B. Newgard (5 shared papers)Brian Timothy O'Neill (7 shared papers)Lynn Bry (3 shared papers)
- Journals
- Diabetes (6 papers)Journal of Clinical Investigation (5 papers)Hepatology (5 papers)Cell Metabolism (4 papers)Nutrients (3 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Samir Softic
58 papers receiving 4.6k citations
Samir Softic's Hit Papers
Peers
Comparison fields: 5 of 111
- Epidemiology 1.7k
- Endocrinology, Diabetes and Metabolism 815
- Hepatology 237
- Geriatrics and Gerontology 89
- Molecular Biology 1.2k
Countries citing papers authored by Samir Softic
This map shows the geographic impact of Samir Softic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir Softic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir Softic more than expected).
Fields of papers citing papers by Samir Softic
This network shows the impact of papers produced by Samir Softic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir Softic. The network helps show where Samir Softic may publish in the future.
Co-authors
The 25 scholars most cited alongside Samir Softic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease Hit paper breakdown → | 2016 | 565 |
| 2 | 2015 | 462 | |
| 3 | 2010 | 320 | |
| 4 | 2004 | 301 | |
| 5 | Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling Hit paper breakdown → | 2017 | 295 |
| 6 | 2013 | 222 | |
| 7 | 2020 | 202 | |
| 8 | 2017 | 200 | |
| 9 | 2019 | 180 | |
| 10 | 2019 | 174 | |
| 11 | 2016 | 153 | |
| 12 | 2016 | 139 | |
| 13 | 2019 | 135 | |
| 14 | 2017 | 128 | |
| 15 | 2016 | 123 | |
| 16 | 2020 | 108 | |
| 17 | 2016 | 101 | |
| 18 | 2023 | 89 | |
| 19 | 2013 | 71 | |
| 20 | 2020 | 61 |
About Samir Softic
Samir Softic is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology, Physiology, Molecular Biology and Biochemistry, having authored 58 papers that have together received 4.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (18 papers), Diet, Metabolism, and Disease (17 papers), Adipose Tissue and Metabolism (6 papers), Metabolism, Diabetes, and Cancer (5 papers), Gut microbiota and health (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Liver physiology and pathology (2 papers) and Muscle Physiology and Disorders (2 papers). The work is most often cited by research in Epidemiology (1.7k citations), Endocrinology, Diabetes and Metabolism (815 citations), Hepatology (237 citations), Geriatrics and Gerontology (89 citations) and Molecular Biology (1.2k citations). Samir Softic has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include C. Ronald Kahn, David E. Cohen, Shiho Fujisaka, Rohit Kohli, Senad Divanovic, Christopher B. Newgard, Brian Timothy O'Neill, Lynn Bry, Siegfried Ussar and Jérémie Boucher. Their work appears in journals such as Diabetes, Journal of Clinical Investigation, Hepatology, Cell Metabolism and Nutrients.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.